We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Further information on what drivers with different types of diabetes need to tell DVLA by law.
Report diabetes treated with Sulphonylureas or Glinide tablets to DVLA if you're a lorry, bus or coach driver.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults.
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
Population screening programmes: NHS diabetic eye screening (DES) programme
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
Report certain types of diabetes to DVLA if you're a lorry, bus or coach driver.
Report diabetes treated with insulin to DVLA if you're a lorry, bus or coach driver.
Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Guidance for the NHS diabetic eye screening (DES) programme.
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
These publications explain diabetic retinopathy and support the NHS diabetic eye screening (DES) programme.
Letter from Dr Rowan Hillson.
How to optimise the NHS Diabetes Prevention Programme in order to identify those at risk of Type 2 diabetes and help lower their risk of developing the disease.
The VIA tool shows how inpatient activity for patients with diabetes differs from a similar patient population without diabetes.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).